Showing results (331-340 of 547) with videos related to
Sort By:
Pageof 55
Angewandte Chemie (International Ed. in English)|July 14, 2019
A Four-Electron Sulfur Electrode Hosting a Cu2+ /Cu+ Redox Charge CarrierXianyong Wu, Aaron Markir, Lu Ma, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategyTsiporah Shore, John Harpel, Michael W Schuster, et al.Leukemia & Lymphoma|March 11, 2015
Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomasPeter Martin, Richard R Furman, Sarah Rutherford, et al.The Gerontologist|May 15, 2018
Establishing the Feasibility of a Tablet-Based Consent Process with Older Adults: A Mixed-Methods StudyNimali Jayasinghe, B Isabel Moallem, Margo Kakoullis, et al.Blood Advances|July 1, 2025
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-AnalysisHerman J van Besien, Neela Easwar, Michelle Demetres, et al.Journal of Pediatric Urology|July 22, 2017
Infant nephrolithiasis and nephrocalcinosis: Natural history and predictors of surgical interventionVeridiana Andrioli, Kerri Highmore, Michael P Leonard, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Secondary Use of Patients' Electronic Records (SUPER): An Approach for Meeting Specific Data Needs of Clinical and Translational ResearchersEvan T Sholle, Joseph Kabariti, Stephen B Johnson, et al.Leukemia & Lymphoma|November 25, 2020
Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a studySven de Vos, John P Leonard, Jonathan W Friedberg, et al.Leukemia & Lymphoma|May 24, 2019
A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphomaPeter Martin, Jia Ruan, Richard Furman, et al.Mbio|February 6, 2026
Synthetic overlapping genes stabilize genetic systemsSean P Leonard, Tiffany M Halvorsen, Bentley Lim, et al.Pageof 55